India could potentially lose $6 billion or 0.16 per cent GDP in exports to the US at 10 per cent broad tariffs, with this ...

Spurious drug manufacturers from other states are tarnishing the image of state’s pharmaceutical industry by using fictitious ...

The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

The Committee was disturbed to find that prosecutions and arrests remain disproportionately low despite the high detection of ...

OA affects about 15-20% of the Indian population, especially the elderly, with women being more vulnerable. It leads to joint ...

The future of healthcare is not just new drugs; it is about smarter, more responsive solutions that prioritise patients ...

Alembic Pharmaceuticals partners with Amlan International to bring innovative poultry health solutions to India's market.

Many firms that participated in the program failed to kickstart production, while others that met manufacturing targets found ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

CCI investigates cartel cases in health and pharma sector, signs global agreements, introduces new mechanisms to combat ...